India's first trans clinic in Hyd gets new lease of life
Mitr Clinic
, India's first exclusive clinic for transgenders set up in 2021 in Narayanguda, had a new lease of life after one of India's top MNCs came to their rescue to fund the clinic after USAID stepped back.
Having reopened on May 2, 2025, the Mitr Clinic has donned a new name - Sabrang. Managed by the YR Gaitonde Centre for AIDS Research and Education (YRGCARE), an NGO focusing on HIV/AIDS treatment, the clinic will be open from Monday to Saturday, 10am to 6pm.
It was in Jan 2025 when the clinic was forced to close after its funding from the United States Agency for International Development (USAID) was halted. All USAID funding was frozen following an order from US President Donald Trump.
As a result, many members of the transgender community who were dependent on the clinic found it difficult to access the healthcare they needed. "Many prefer to come to this clinic since it provides privacy to the transgender community. Until Jan, the clinic used to serve 350 members of the LGBTQIA+ community," said a member of the community.
For 24-year-old Radhakrishnan, who works as a traffic assistant with the state police, Sabrang is where he hopes to continue his transition to a trans man. "For a few months, when the clinic was closed, I struggled. I was used to visiting Mitr regularly for hormone therapy. I had nowhere else to go when it was shut," he said.
Similarly, Ayesha Meera, a transgender woman who used to work as a counsellor for Mitr and now works as an advocacy officer for the Trans Equality Society, said: "I used to live in Tenali and travel 7-8 hours every day for hormone therapy at Mitr. Now that the clinic is open again, I can continue doing it."
Meanwhile, June being Pride Month, the clinic manager organised a pot-luck on Saturday, attended by their regular patients. "Here, I am not made to feel ashamed, and I feel comfortable. At other clinics, I was taunted and looked down upon," a transgender person told TOI.
"The HIV treatment programme is extensive. They provide PREP (Pre-Exposure Prophylaxis, a medication to prevent HIV, anti-retroviral therapy, and PEP (Post-Exposure Prophylaxis, a medication to cure HIV). It's also a place for the community to socialise and bond - it's more like a second home," said Rohit Mohite, a sexual health manager.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
13 hours ago
- Indian Express
Trump's domestic policy bill draws fire over Medicaid cuts, as democrats begin campaign blitz
President Donald Trump's wide-ranging domestic policy bill, passed by Congress this week, is facing growing criticism over its planned cuts to Medicaid. The bill, which is is now just hours away from becoming law, includes nearly $1 trillion in Medicaid reductions over a decade, a move Democrats are using to launch early attacks ahead of the 2026 midterm elections. For months, some Republican lawmakers had raised concerns. North Carolina Senator Thom Tillis said the cuts were 'inescapable,' while Missouri Senator Josh Hawley said targeting Medicaid was 'a mistake.' Nebraska Representative Don Bacon had earlier said he would not back a bill with over $500 billion in cuts but explained he ended up supporting it due to other tax and defence provisions. Democrats are now highlighting those Republican warnings. 'It's 2018 all over again,' said Democratic Representative Jared Golden of Maine, who holds a seat in a pro-Trump district. 'I would never vote for these Medicaid cuts. Never,' Golden told CNN. A June poll by Quinnipiac University found that 53% of voters opposed the bill. While Republicans argue the cuts mostly involve new work requirements for able-bodied adults without dependents, Democrats say millions could eventually lose coverage. The Congressional Budget Office estimates around 12 million people could lose health insurance by 2034 due to changes in Medicaid and the Affordable Care Act. Trump praised the bill at an event in Iowa, while House Speaker Mike Johnson called it one of the most complex and significant pieces of legislation in US history. Speaking after signing the bill, Johnson said it was among 'the top two or three' bills ever passed in Congress, according to CNN.
Time of India
14 hours ago
- Time of India
From coverage to crisis? How Trump's tax package could strip millions of Medicaid benefit
With Trump's tax cuts extended and Medicaid restrictions tightened, the bill is poised to redraw the contours of America's healthcare landscape. Its long-term impact will depend on how states choose to implement the new rules. Tired of too many ads? Remove Ads Safety-Net Shake-Up: Medicaid in the Crosshairs Tired of too many ads? Remove Ads Mandated Work Requirements and Eligibility Checks Changes to Medicaid Financing: States to Feel the Pinch Tired of too many ads? Remove Ads Republican Defense: Work for Welfare Consumer Watchdogs Worry About Mounting Medical Debt A Step Backward from Universal Healthcare? FAQs What does the new law say about Medicaid? How many people could lose health coverage because of this bill? Millions of Americans enrolled in Medicaid are set to face significant changes as the U.S. Congress approved President Donald Trump's expansive tax and spending package this week. While the bill extends key components of Trump's tax cuts, it also includes deep reductions in federal healthcare support—prompting growing anxiety among health policy experts and consumer newly passed legislation, which cleared the U.S. Senate on July 1 and the House of Representatives on July 3, is expected to reduce federal healthcare expenditures by nearly $1 trillion over the next decade. A substantial portion of these cuts target Medicaid and the Affordable Care Act (ACA) insurance to projections by the Congressional Budget Office (CBO), the law will result in 11.8 million Americans losing health coverage, with an additional 5 million affected by the discontinuation of pandemic-era tax credits that had subsidized ACA which provided health insurance to 78.6 million low-income Americans as of March 2025, will now come under stricter eligibility surveillance, including job verification requirements and reduced financial leeway for states to fund their share of the programme.A defining element of the bill is its imposition of work requirements on certain Medicaid recipients. Beginning in 2027, states that expanded Medicaid under the ACA must verify twice a year that "able-bodied" beneficiaries are employed for at least 80 hours per month or meet exemption criteria—such as being a caregiver, student, or of children above 13 years will also be subjected to these checks. States will be obligated to set up systems for regular job verification, though the Department of Health and Human Services can grant implementation delays through waivers for those acting in "good faith."During Trump's first term, 13 states sought similar waivers. Only Arkansas implemented them before a federal court halted the programme, which had disenrolled 18,000 people within seven months. Currently, Georgia operates the only state-approved Medicaid work requirement scheme, known as "Georgia Pathways," with fewer than 7,500 people eligibility criteria, the bill also reforms how states can finance Medicaid. Many states have used 'provider taxes'—fees on hospitals and other healthcare providers—to boost their federal Medicaid match. The new law freezes the current tax limit and then, beginning in 2028, lowers the allowable rate from 6% to 3.5%, as per a report by USA policy analysts believe this reduction could pressure states to reduce healthcare services or reconsider their expansion commitments under the ACA.'States are going to anticipate that loss of revenue and will be looking to make changes,' said Jennifer Tolbert, Deputy Director at KFF's Medicaid and Uninsured critics describe the bill as a rollback of Obama-era healthcare reforms, Republican lawmakers argue that the overhaul is a necessary realignment of federal assistance Mike Johnson, speaking before the House vote, defended the inclusion of work requirements, stating that they aim to 'restore dignity and purpose to those on taxpayer-funded benefits.'The bill also aligns with Trump's broader campaign promise to extend his 2017 tax cuts, eliminate taxes on tips and overtime, and ramp up border security—creating a sweeping fiscal package that redefines government spending advocacy groups warn that the new law could lead to a rise in medical debt, particularly among vulnerable populations who lose insurance debt already constitutes more than half of all debt in collections, as per a 2022 report from the Consumer Financial Protection Bureau (CFPB). A Biden-era rule intended to ban medical debt from credit reports is now at risk, as the GOP-led bill includes funding cuts to the CFPB, potentially weakening its ability to implement consumer protections.'The combination of reduced healthcare access and a weakened consumer watchdog agency is a double blow,' said Sally Greenberg, CEO of the National Consumers League. 'Consumers are going to pay—and patients are going to pay big time.'Health policy researchers view the legislation as a significant departure from the universal coverage ambitions of the Obama-era ACA.'This is a giant step backwards from the vision of universal coverage that was President Obama's legacy,' said Joan Alker, Executive Director of Georgetown University's Center for Children and Trump's tax cuts extended and Medicaid restrictions tightened, the bill is poised to redraw the contours of America's healthcare landscape. Its long-term impact will depend on how states choose to implement the new rules—and how millions of Americans adjust to a potentially leaner public health safety newly passed legislation includes nearly $1 trillion in federal healthcare cuts over the next decade, with a significant portion targeting Medicaid. The law introduces work requirements, tighter eligibility checks, and limits on how states fund to the Congressional Budget Office (CBO), 11.8 million Americans are projected to lose health insurance coverage due to the Medicaid reductions and the expiration of pandemic-era tax credits for ACA plans.
Hans India
a day ago
- Hans India
IISc develops simple sensor for detecting liver cancer
Researchers at the Indian Institute of Science (IISc) Bangalore have developed a simple sensor that is cost-effective and can enable faster detection of liver cancer. The team focussed on the potential of terbium -- a rare earth metal -- to develop a unique luminescent probe that can sense the presence of an enzyme called beta-glucuronidase. While its core function is to break down a sugar acid called glucuronic acid, the enzyme also doubles as a critical biomarker for liver cancer. An increase in beta-glucuronidase levels has been associated with the risk of colon, breast, and renal cancers, as well as infections of the urinary tract and AIDS. Thus, the novel sensor offers a potentially powerful screening tool against different types of cancers, neonatal jaundice, and NSAID-induced toxicity, said the researchers. 'Conventional methods of colorimetry and fluorescence for detecting such enzymes are often restricted by sensitivity or interference from background signals. The ability of rare earth metals to have long-lived excited states allows us to filter out short-lived background fluorescence, resulting in a much clearer signal,' said Ananya Biswas, former PhD student at IISc and co-first author of the paper published in the journal Chemistry. The innovation began with research into the gel-forming properties of metal ions. The IISC team discovered that terbium ions, when incorporated into a gel matrix derived from bile salts, emitted a bright green glow. To this, the researchers added a molecule called 2,3-DHN ((2,3-Dihydroxynaphthalene), masked with glucuronic acid. In the presence of beta-glucuronidase, terbium ions cleave the mask, releasing 2,3-DHN, which then acts as an 'antenna,' absorbing UV light. It also transfers energy to nearby terbium ions, amplifying the green fluorescence, explained Uday Maitra, Professor in the Department of Organic Chemistry, IISc. Further, to make the technology accessible, the team embedded the gel matrix onto paper discs, creating a simple and portable sensor. Exposing the samples containing beta-glucuronidase, these discs emitted a pronounced green glow under UV light. These sensors could also be analysed using a UV lamp and ImageJ -- an open source, freely accessible software, making this technique ideal for resource-limited settings, the team said. The sensor showed a detection limit, which was significantly below the beta-glucuronidase levels typically seen for cirrhosis -- an advanced stage of liver disease. While more clinical studies are needed to validate the findings, such sensors can bring down the cost of detecting clinically significant biomarkers, the researchers said.
